SeaStar Medical Holding Corp (ICU): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$7.52M

Year ended 2025-12-31

$8.91M

Trailing 12 months to 2026-06-30

+44.3%

3-year compound annual growth

2021-12-31 R&D Expense (USD) 2025-12-31

Period ended	R&D Expense	Change YoY	Source filing
2025-12-31	$7.52M	-17.4%	2026-03-25, From 2025-01-01
2024-12-31	$9.11M	+52.4%	2026-03-25, From 2024-01-01
2023-12-31	$5.97M	+138.6%	2025-03-27, From 2023-01-01
2022-12-31	$2.50M	n/c	2024-04-16, From 2022-01-01
2021-12-31	$2.77M	n/a	2023-03-30, From 2021-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	R&D Expense	Change YoY
SeaStar Medical Holding Corp (ICU)	2025-12-31	$7.52M	-17.4%
PetVivo Holdings, Inc. (PETV)	2026-03-31	$1.42M	-10.6%
RenovoRx, Inc. (RNXT)	2025-12-31	$6.27M	+4.0%
Sintx Technologies, Inc. (SINT)	2025-12-31	$4.59M	-11.8%
EBR Systems, Inc. (NONE.)	2025-12-31	$23.94M	-11.5%
Catheter Precision, Inc. (VTAK)	2025-12-31	$862.0K	+216.9%
Vycor Medical Inc (VYCO)	2025-12-31	$10.0K	-35.0%
Harvard Apparatus Regenerative Technology, Inc. (HRGN)	2025-12-31	$2.65M	+14.8%
Femasys Inc (FEMY)	2025-12-31	$7.58M	-7.8%

Compare ICU, PETV, RNXT, SINT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗